477 Topical treatment of human skin and cultured keratinocytes with high-dose spironolactone reduces XPB expression and induces genotoxicity

Saved in:
Bibliographic Details
Published inJournal of investigative dermatology Vol. 141; no. 5; p. S83
Main Authors Carpenter, M.A., Kemp, M.G.
Format Journal Article
LanguageEnglish
Published 01.05.2021
Online AccessGet full text

Cover

Loading…